The verified answer
As of Sep 2026, DEPLOY verifies Neptune Medical: 1 model, $291.0M raised. 2 sources back the record.
CategorySurgical robots
Overview
Menlo Park, CA-based GI robotics developer. Founder/CEO Alex Tilson. $97M Series D (August 2024). Investors: Sonder Capital, Olympus Corporation. Product: Pathfinder sleeve (wraps around endoscope, stiffens to prevent loops). Subsidiaries: Jupiter Endovascular (spun out with $21M, Endoportal Control for pulmonary embolism, led by Carl St. Bernard), Triton Medical Robotics (flexible endoluminal surgical device). Focus: GI robotics.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
Series D
Founder/CEO
Product
Subsidiaries
HQ
Data & sources
Web sources
2
2 sources backing this record.View all →
Models (1)
View all models →Neptune Medical on the deployment map
View the global mapNeptune Medical has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Neptune Medical on the DEPLOY record yet. Track Neptune Medical to know the moment the first one is verified.
Current leadership (2)
- Alex Tilson Founder & CEOreported, not verified
- Fred Moll Chairman of the Boardsecondary-verified
Founders (1)
- Alex Tilsoncofounderno longer at company
Safety record
No incidents on record for Neptune Medical.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Neptune Medical in third-party press
Inside Biotech: Healthcare robotics enters its next phase as GI systems gain momentum - Proactive financial news
Neptune Medical’s GI robot succeeds in colonoscopy study - MedTech Dive
50-Patient First-in-Human Study of Triton Robotic Endoscopy System From Neptune Medical Demonstrates No Adverse Events and 100% Cecal Intubation in Colonoscopy - Business Wire
Financial state
- Total funding
- $291.0M
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- early
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (3)
Neptune Medical’s 3 disclosed rounds, $291M in total, oldest to newest.
- Series D
$97M(reported)
- Series D
$97M(reported)
- Series D
$97M(reported)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 22, 2026
Added to the verified registry
Sources (2)
Common questions
What is Neptune Medical?
What does Neptune Medical make?
Is Neptune Medical publicly traded?
Who is the CEO of Neptune Medical?
How can I invest in Neptune Medical?
Where is Neptune Medical headquartered?
How much funding has Neptune Medical raised?
Who owns Neptune Medical?
Where does Neptune Medical operate robots?
Is Neptune Medical a top robotics company?
Is Neptune Medical safe?
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 2
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Neptune Medical.In the press
Recent coverage mentioning Neptune Medical from third-party publications. Automatically surfaced; not part of the verified registry record.
Inside Biotech: Healthcare robotics enters its next phase as GI systems gain momentum - Proactive financial news
<a…
Neptune Medical’s GI robot succeeds in colonoscopy study - MedTech Dive
<a…
50-Patient First-in-Human Study of Triton Robotic Endoscopy System From Neptune Medical Demonstrates No Adverse Events and 100% Cecal Intubation in Colonoscopy - Business Wire
<a…
Neptune Medical Announces New Data Demonstrating That Pathfinder Endoscope Overtube Enables Completion of Diagnostic and Therapeutic Procedures in Challenging Anatomy - Business Wire
<a…
Nvidia outlines new AI projects in robotic surgery, autonomous imaging - Fierce Biotech
<a…
Neptune Medical to utilize Nvidia AI in GI robotic system - MassDevice
<a…
Neptune Medical to Advance GI Robotics with NVIDIA Isaac for Healthcare - Business Wire
<a…
Introducing NVIDIA Isaac for Healthcare, an AI-Powered Medical Robotics Development Platform - NVIDIA Developer
<a…
Key patents indicate future trajectory for surgical robotics and reveal necessary IP management insights - IAM Patent
<a…
Neptune Medical: $97 Million (Series D) Raised And Jupiter Endovascular Spins Out - Pulse 2.0
<a…
Wilson Sonsini Advises Neptune Medical on $97 Million Series D Financing - Wilson Sonsini
<a…
GI robotics developer Neptune Medical raises $97M, launches Jupiter Endovascular - Fierce Biotech
<a…
Machine-readable surfaces
- Markdown mirror: /companies/neptune-medical.md
- RSS feed: /companies/neptune-medical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/79af1772-cc80-4ac7-abe1-60a8ea799ed8
- Revision history: /companies/neptune-medical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Video
#homecare #healthcare #elderly #patient Welcome to contact us: https://www.medicalxm.com/
In this episode, I go deep inside one of the most advanced robotics labs in Silicon Valley, SRI International, to go behind the scenes with Medical Devices Corn
Subscribe for new videos - http://bit.ly/SubscribeHMH Learn more about Hackensack Meridian Health - http://bit.ly/HMHWeb Listen and subscribe to our Podcast
In this interview, Andy Pierce, group president of MedSurg and Neurotechnology, details how the company strives to create products that nurses and hospital staf
Heat Index
Category contender75/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Neptune Medical draws attention at the 71st percentile but verifies reality at the insufficient-data level among surgical robots.
6-month trend
Analysis
Limited public funding data for capital position assessment.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 8, 2026